Announcement
17 Jun 2022
In June 2022, the Norwegian authorities introduced an export ban on alteplase following the outbreak of COVID-19.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
17 Jun 2022
Revocation date:
01 Jul 2023
Updated: 17 Jun 2022
Export ban
On 17 June 2022, the Norwegian Medicines Agency introduced an export ban on alteplase. More specifically, the export ban concerns powders and infusion/injection solutions. The export ban was introduce...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.